Yes and No. 

Yes, the poster on akaline phosphatase is available as of yesterday. "Apabetalone, an Inhibitor of BET Proteins, Downregulates Alkaline Phosphatase and Improves Cardiovascular Risk."

No, the oral BETonMACE presentation has not happened yet.....looks to be on the schedule for tomorrow 10/24. "Effect of Apabetalone on Major Adverse Cardiovascular Events in Patients with CKD, Diabetes, and Recent Acute Coronary Syndrome: Results from the BETonMACE Trial."

BDAZ